Document is current
Any future updates will be listed below
-
Authors
Kazama, Shingo
Morimoto, Ryota https://orcid.org/0000-0003-0931-3188
Kimura, Yuki
Shibata, Naoki
Ozaki, Reina
Araki, Takashi
Mizutani, Takashi
Oishi, Hideo
Arao, Yoshihito
Kuwayama, Tasuku
Hiraiwa, Hiroaki
Kondo, Toru
Furusawa, Kenji
Shimokata, Tomoya
Okumura, Takahiro
Bando, Yasuko K.
Ando, Yuichi
Murohara, Toyoaki
- License Information
-
More Information
Article History
Received: 26 February 2021
Accepted: 25 June 2021
First Online: 6 July 2021
Declarations
:
: We obtained prior approval that the study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki from the Ethics Committee of Nagoya University Hospital (approval number 2019–0176). There was no need for written consent or consent for publication.
: Not applicable.
: TO has received research grants from Ono Pharmaceutical Co., Ltd., Bayer Pharmaceutical Co., Ltd., Daiichi-Sankyo Pharma Inc., and Amgen Astellas BioPharma K.K. outside the submitted work. TO received honorariums from Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Novartis Pharma K. K., and Medtronic Japan Co., Ltd.YA received grants and personal fees from Chugai Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Nippon Kayaku Co., Yakult Honsha Co., Ltd., Eli Lilly Japan K.K., Mochida Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Daiichi Sankyo Company, Ltd., Eisai Co., Ltd., personal fees from Novartis Pharma K.K., Bayer Holding Ltd., Bristol-Myers Squibb, Sawai Pharmaceutical Co., Ltd., Tsumura & Co., Otsuka Holdings Co., Ltd., Roche Pharmaceutical Industries Ltd., outside the submitted work.TM received lecture fees from Bayer Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Pfizer Japan Inc., Sanofi-aventis K. K., and Takeda Pharmaceutical Co., Ltd. TM received unrestricted research grant for Department of Cardiology, Nagoya University Graduate School of Medicine from Astellas Pharma Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Otsuka Pharma Ltd., Pfizer Japan Inc., Sanofi-aventis K. K., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd. The remaining authors have nothing to disclose.
